ASGR1 and cancer: The MSN-LA-SO@siVEGF nanocarrier induced synthesis (S) phase cell-cycle arrest, increasing the anti-cancer efficacy (cell apoptosis) of SO and siVEGF through the active targeting of LA in ASGPR-overexpressing Huh7 tumoral cells.